Defining the impact of mutational drivers on the immune microenvironment of CLL

定义突变驱动因素对 CLL 免疫微环境的影响

基本信息

  • 批准号:
    10558675
  • 负责人:
  • 金额:
    $ 20.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary The dynamic interactions of tumor cells with their microenvironment play an essential role in stimulating cancer progression, and likely contribute to the pace of clonal evolution and therapeutic resistance. Emerging evidence suggests that genetic features of cancer cells may impact composition and function of immune cells within the tumor microenvironment (TME), yet evidence for this remains scant. Recently, we have generated several novel conditional knock-in/out mouse models of chronic lymphocytic leukemia (CLL) driven by B-cell restricted expression of human CLL lesions, providing opportunities to model the vast genetic heterogeneity of human cancers within an immune-competent microenvironment. This current projects seeks to use single cell RNA sequencing (scRNA-seq) and functional assays to determine the CLL-microenvironment interactions in these CLL mouse models, and validate the findings in human CLLs. In particular, we will: (Aim 1) Discover the impact of CLL driver events on the CLL immune landscape. Through scRNA-seq analyses, we will characterize the immune landscape within the CLL microenvironment, examining both the spleen and bone marrow (BM) compartments in age-matched controls (Cd-19 Cre transgenic mice) and 4 different genetically-defined CLL mouse models (Cd19-Cre × MDR, mut-Sf3b&Atm, mut-Ikzf3 and Dnmt3a-deleted). Building on our intriguing pilot scRNA-seq study conducted in the Dnmt3a-deleted model, we now propose to cross compare the composition and transcriptional states of immune cells in each model, and to determine whether there are consistent or unique model-dependent interactions between CLL and immune populations. (Aim 2) Validate candidate mediators of CLL-TME interactions. We anticipate that we will identify microenvironment changes of interest either found in common or unique amongst the models, and we will perform flow cytometry and immunofluorescence (IF)/immunohistochemical (IHC) staining on independent mouse specimens for validation. We will also perform in vitro co-culture experiments and in vivo transplantation to study the functional interaction between CLL cells and particular immune cell populations of interest. Indeed, our pilot data from the Dnmt3a- deleted CLL mouse spleen has already identified an expanded subpopulation of dysregulated dendritic cells, and we will evaluate if this change is also observed across the other models and the extent to which this change regulates CLL development. (Aim 3) Confirm the effects of CLL driver events in the TMEs of human CLL. We will cross compare the mouse scRNA-seq data with that of an existing human CLL scRNA-seq data generated in the Wu lab. We will perform IF/IHC staining of LN and BM samples from CLL patients to further validate promising signatures. Altogether, the proposed analyses will expand our knowledge on how cancer cell-intrinsic features can remodel the tumor immune microenvironment, and has the potential to contribute to the rational design of personalized cancer immunotherapy.
项目摘要 肿瘤细胞与其微环境的动态相互作用在刺激癌症方面起着至关重要的作用 进展,并可能有助于克隆进化和治疗耐药的速度。新出现的证据 提示癌细胞的遗传特征可能会影响体内免疫细胞的组成和功能 肿瘤微环境(TME),但这方面的证据仍然很少。最近,我们创作了几部小说 B细胞限制性驱动的慢性淋巴细胞白血病(CLL)条件性基因敲除小鼠模型 人类CLL损伤的表达,为模拟人类巨大的遗传异质性提供了机会 处于免疫能力强的微环境中的癌症。目前的项目寻求使用单细胞RNA 测序(scRNA-seq)和功能分析以确定这些细胞中CLL-微环境的相互作用 CLL小鼠模型,并在人类CLL中验证这一发现。特别是,我们将:(目标1)发现影响 在CLL免疫版图上的CLL驱动程序事件。通过scRNA-seq分析,我们将表征 CLL微环境中的免疫景观,同时检查脾和骨髓(BM) 年龄匹配的对照组(CD-19 Cre转基因小鼠)和4种不同基因定义的CLL的间隔 小鼠模型(CD19-CRE×MDR,MUT-SF3B和ATM,MUT-IKZF3和DNMT3A-缺失)。在我们引人入胜的基础上 在DNMT3A缺失模型中进行的试点scRNA-seq研究,我们现在建议交叉比较 每种模型中免疫细胞的组成和转录状态,并确定是否存在 CLL和免疫群体之间一致或独特的依赖于模型的交互作用。(目标2)验证 CLL-TME相互作用的候选介体。我们预计,我们将确定微环境的变化 感兴趣的或共同或独特的模型,我们将进行流式细胞术和 对独立的小鼠标本进行免疫荧光(IF)/免疫组织化学(IHC)染色以进行验证。 我们还将进行体外共培养实验和体内移植,以研究功能相互作用。 CLL细胞和特定免疫细胞群之间的关系。事实上,我们来自DNMT3A的试验数据- 删除CLL小鼠的脾已经发现了一个扩大的失调树突状细胞亚群,并且 我们将评估是否在其他模型中也观察到了这种变化,以及这种变化的程度 调节CLL的发育。(目的3)证实CLL驱动事件在人类CLL的TME中的作用。我们 将鼠标scRNA-seq数据与已生成的人类CLL scRNA-seq数据进行交叉比较 在吴的实验室。我们将对CLL患者的LN和BM样本进行IF/IHC染色,以进一步验证 有希望的签名。总之,拟议的分析将扩大我们对癌细胞如何内在地 功能可以重塑肿瘤免疫微环境,并有可能有助于合理 个性化癌症免疫疗法的设计。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Catherine Ju-Ying Wu其他文献

Catherine Ju-Ying Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Catherine Ju-Ying Wu', 18)}}的其他基金

Defining the impact of mutational drivers on the immune microenvironment of CLL
定义突变驱动因素对 CLL 免疫微环境的影响
  • 批准号:
    10357003
  • 财政年份:
    2022
  • 资助金额:
    $ 20.39万
  • 项目类别:
Antigenic basis of immune responses after immune modulatory therapies post-HCT
HCT 后免疫调节治疗后免疫反应的抗原基础
  • 批准号:
    10465094
  • 财政年份:
    2019
  • 资助金额:
    $ 20.39万
  • 项目类别:
Antigenic basis of immune responses after immune modulatory therapies post-HCT
HCT 后免疫调节治疗后免疫反应的抗原基础
  • 批准号:
    10218090
  • 财政年份:
    2019
  • 资助金额:
    $ 20.39万
  • 项目类别:
Defining the determinants of response and resistance to therapy for Richter's Syndrome
定义里氏综合症治疗反应和耐药的决定因素
  • 批准号:
    10491142
  • 财政年份:
    2016
  • 资助金额:
    $ 20.39万
  • 项目类别:
Comprehensive dissection of the CLL genome and phenome to improve patient outcomes
全面剖析 CLL 基因组和表型组以改善患者预后
  • 批准号:
    9548911
  • 财政年份:
    2016
  • 资助金额:
    $ 20.39万
  • 项目类别:
Defining the determinants of response and resistance to therapy for Richter's Syndrome
定义里氏综合症治疗反应和耐药的决定因素
  • 批准号:
    10270038
  • 财政年份:
    2016
  • 资助金额:
    $ 20.39万
  • 项目类别:
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
CLL 基因组的全面剖析
  • 批准号:
    10270036
  • 财政年份:
    2016
  • 资助金额:
    $ 20.39万
  • 项目类别:
Comprehensive dissection of the CLL genome and phenome to improve patient outcomes
全面剖析 CLL 基因组和表型组以改善患者预后
  • 批准号:
    9149996
  • 财政年份:
    2016
  • 资助金额:
    $ 20.39万
  • 项目类别:
Comprehensive dissection of the CLL genome and phenome to improve patient outcomes
全面剖析 CLL 基因组和表型组以改善患者预后
  • 批准号:
    9445777
  • 财政年份:
    2016
  • 资助金额:
    $ 20.39万
  • 项目类别:
CLL clonal evolution and the development of therapy-driven resistance
CLL 克隆进化和治疗驱动耐药性的发展
  • 批准号:
    10005158
  • 财政年份:
    2016
  • 资助金额:
    $ 20.39万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 20.39万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 20.39万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 20.39万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 20.39万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 20.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 20.39万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 20.39万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 20.39万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 20.39万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 20.39万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了